Givaudan | GIVN - Current Assets


Givaudan reported CHF4.07B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Air Liquide EUR 9.99B 1.95B Dec/2025
Akzo Nobel EUR 7.53B 1.47B Mar/2026
Anheuser-Busch USD 24.77B 3.55B Dec/2025
Arkema EUR 4.84B 11.8M Mar/2026
Associated British Foods GBP 6.2B 225M Dec/2025
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
British American Tobacco GBP 12.68B 1.19B Dec/2025
Covestro EUR 5.91B 259M Dec/2025
Croda International GBP 884.2M 36.4M Dec/2024
Danone EUR 13.23B 332M Dec/2025
Diageo GBP 18.89B 1.4B Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Givaudan CHF 4.07B 258M Dec/2025
Heineken EUR 12.89B 1.81B Dec/2025
Henkel EUR 10.07B 268M Dec/2025
International Flavors Fragrances USD 5.44B 157M Mar/2026
Johnson Matthey GBP 3.94B 105M Jun/2026
Kerry EUR 4.04B 808.7M Dec/2024
Lonza CHF 8B 3.41B Dec/2025
L'Oréal EUR 22.2B 3.92B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Nestle CHF 31.97B 1.46B Dec/2025
Pernod Ricard EUR 13.04B 751M Dec/2025
Reckitt Benckiser GBP 4.6B 287M Dec/2024
SGS CHF 2.85B 186M Dec/2024
Sika AG CHF 4.41B 242.1M Dec/2025
Solvay EUR 2.19B 34M Mar/2026
Tate & Lyle GBP 1.33B 73M Jun/2026
Umicore EUR 5.74B 881.2M Dec/2025
Victrex GBP 189.3M 3.9M Jun/2026